Skip to main content

Table 3 Two-year programmatic costs of targeted MDA with different numbers of villages selected for targeted MDA

From: Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar

Cost of screening 272 villages using uPCR Percentage of villages with targeted MDA Number of villages Cost of community engagement Cost of mass treatment Total cost Cost per villagea Cost per person reachedb
541,042 1% 13 56,735 111,551 709,328 579 1.9
541,042 2% 25 61,534 155,684 758,260 618 2.1
541,042 3% 37 66,332 199,816 807,190 658 2.2
541,042 4% 50 71,531 247,626 860,199 702 2.4
541,042 5% 62 76,330 291,759 909,131 742 2.5
541,042 6% 74 81,128 335,891 958,061 781 2.6
541,042 7% 86 85,927 380,024 1,006,993 821 2.8
541,042 8% 99 91,126 427,834 1,060,002 865 2.9
541,042 9% 111 95,924 471,966 1,108,932 905 3.0
541,042 10% 123 100,732 516,099 1,157,864 944 3.2
  1. aCost per village is estimated by dividing the total cost of targeted MDA by the total number of villages in the four townships (1226 villages). These targeted MDA costs will be shared among all villages in the region because targeted MDA is provided in addition to other malaria interventions, so the total cost is distributed among all villages in the region
  2. bCost per person reached is calculated by the total cost divided by the total population in that area (365000)
  3. MDA Mass drug administration; uPCR Ultrasensitive polymerase chain reaction